Vaccine-resistant pneumonia has increased since a vaccine targeting 13 serotypes of the Streptococcus pneumoniae bacteria was introduced into the Australian routine childhood immunisation program.
The Kirby Institute is calling for people at risk of monkeypox to enrol in the TraX study to help shape the public health response.
The third-generation vaccine has fewer potential side effects than second-generation vaccines and can be safely given to people with weakened immune systems.
mRNA is the key ingredient in COVID-19 vaccines. But what is it, and how does it work?
While public health measures in schools and hospitals aim to reduce COVID transmission, people with disability who have support workers in their homes have largely been forgotten.
Variant-specific vaccines would undoubtedly increase immunity. But waves of new variants would engulf the population faster than these vaccines could ever be deployed.
In a new survey, almost two-thirds of parents reported having trouble securing a vaccination for their child or children with disability.
Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of Pfizer's and other mRNA vaccines.
This is the key number that will determine when we can stop living under the shadow of COVID
COVID has highlighted the differences in healthcare affordability across the globe, with a glimpse into what the future of medicine could look like if we don’t act.